Phase I/Ib Clinical Trial of ABTL0812 in Advanced Cancer Patients

Update Il y a 5 ans
Reference: NCT02201823

Woman and Man

  • | Country :
  • Spain
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Ability Pharmaceuticals promotes a clinical trial to determine the adequate dose of a new drug, ABTL0812, that will be administered orally daily to patients with advanced solid tumors.


Inclusion criteria

  • Cancer

Links